• Annexin V-Cy5 Apoptosis Kit for Microglia Studies

  2026-09-15

  Use the Annexin V-Cy5 Apoptosis Kit to separate phosphatidylserine exposure and cell-death signaling from lysosomal stress in microglia models. Its rapid workflow supports both spatial fluorescence microscopy apoptosis analysis and quantitative flow cytometry apoptosis detection.

• LNP-Delivered NGFR100W mRNA for Peripheral Neuropathy

  2026-09-15

  The reference study engineered a chemically modified NGFR100W mRNA and delivered it with lipid nanoparticles to produce a neuroprotective NGF variant with less nociceptive activity than wild-type NGF. Its results connect sequence engineering, transient protein expression, and recovery of nerve pathology in a paclitaxel-induced neuropathy model, while also illustrating how mRNA can accelerate preclinical evaluation of therapeutic proteins.

• Peroxynitrite–Ca2+ Signaling in Cardiac I/R Injury

  2026-09-14

  Liu et al. define a mechanistic link between hyperhomocysteinemia, peroxynitrite-driven ER stress, IP3R-dependent Ca2+ transfer, and cardiac microvascular endothelial necroptosis during ischemia–reperfusion. The study combines human cardiac microvascular endothelial-cell and rat models to identify pathological Ca2+ flux as an intervention point and demonstrates that IP3R inhibition improves infarct and cardiac-function outcomes.

• Baicalin methyl ester: Intestinal Barrier Workflow

  2026-09-14

  Baicalin methyl ester supports mechanism-aware LPS-induced intestinal barrier damage research by connecting inflammatory cytokines with tight-junction and MLCK readouts. This practical guide covers cell-based screening, mouse dose translation, assay controls, and troubleshooting for reproducible intestinal inflammation studies.

• Cy3 NHS ester (non-sulfonated): Practical Guide

  2026-09-13

  Cy3 NHS ester (non-sulfonated) provides an orange fluorescent label for primary amines on proteins, peptides, oligonucleotides, and DNA. It is suitable for workflows that tolerate DMSO, DMF, or another compatible organic co-solvent, but it is not a good choice for aqueous-only labeling of delicate proteins because the reagent is insoluble in water.

• From Orthopoxvirus Antibodies to Better Detection

  2026-09-12

  Translational antibody programs succeed when discovery, assay design, and evidence strategy advance together. This thought-leadership article connects M1R/B6R orthopoxvirus antibody research with practical human-IgG detection workflows built around the Cy3 Goat Anti-Human IgG (H+L) Antibody.

• 3-Deazaneplanocin (DZNep) Workflow Guide

  2026-09-11

  3-Deazaneplanocin (DZNep) connects S-adenosylhomocysteine hydrolase inhibition with EZH2-linked epigenetic remodeling, making it useful for apoptosis studies, tumor-initiating cell assays, and mechanism-focused oncology workflows. This guide translates product-backed conditions and receptor-aware experimental design into practical setup, optimization, and troubleshooting strategies.

• EPZ5676: Rethinking DOT1L Translation

  2026-09-11

  EPZ5676 illustrates how a highly selective SAM-pocket mechanism can connect DOT1L inhibition with H3K79 methylation, MLL-fusion transcriptional programs, and leukemia phenotypes. This translational guide moves beyond product specifications to outline evidence chains, assay strategy, model selection, and responsible interpretation.

• SW033291: 15-PGDH Inhibitor Workflows

  2026-09-10

  SW033291 connects biochemical 15-PGDH inhibition with prostaglandin E2 elevation, marrow-cell signaling, and tissue regeneration research. This workflow-focused guide shows how to move from enzyme kinetics to cellular validation while interpreting emerging muscle-repair findings without overstating translational maturity.

• Oltipraz Workflows for Nrf2 Liver Research

  2026-09-10

  Build reproducible Nrf2 and phase II enzyme assays with Oltipraz, then extend the design to oxidative injury and MASLD-related liver research. The workflow separates direct pathway activation from the broader autophagy–ferroptosis biology reported for Qushi Huoxue ointment, improving mechanistic interpretation.

• EZ Cap™ Cy5 EGFP mRNA: Assay Design Guide

  2026-09-09

  EZ Cap™ Cy5 EGFP mRNA (5-moUTP) combines Cy5-labeled mRNA tracking with EGFP expression to separate cellular delivery from translation. This guide applies the reporter to LNP heterogeneity, assay controls, and structure–function decisions beyond conventional transfection readouts.

• Doxorubicin Workflows for Senescence Assays

  2026-09-09

  Use Doxorubicin as a controlled DNA-damage and apoptosis benchmark when testing senolytic or senomorphic candidates. This workflow connects oncology-grade assay rigor with the Lactobacillus plantarum DS0037 nanovesicle findings while preserving the distinction between selective cell killing and SASP modulation.

• Goat anti-rabbit IgG secondary antibody workflow

  2026-09-08

  Build reproducible red-channel detection into plaque biology, cell imaging, tissue pathology, flow cytometry, and ELISA workflows with a fluorophore-conjugated secondary antibody. The HyperFluor™ 594 format combines broad rabbit IgG recognition with application-specific dilution guidance and practical storage safeguards.

• Designing Better mRNA Reporter Assays

  2026-09-08

  A mechanistic and translational guide to using Cap1, m1Ψ-modified Firefly Luciferase mRNA for separating delivery, translation, cell health, and expression kinetics while interpreting new evidence on synthetic mRNA fidelity.

• Trilaurin (Glycerol Tridodecanoate) Protocol Guide

  2026-09-07

  Trilaurin (Glycerol Tridodecanoate, SKU BA7536) is a water-insoluble C12 triacylglycerol used as a lipid excipient, formulation component, and biocatalytic synthesis substrate. This guide covers solvent selection, short-term handling, particle-formulation workflows, and enzyme-reaction QC while defining why it should not be treated as a direct aqueous reagent or routinely stored as a long-term solution.

8131 records 1/543 page Next 12345 下5页 Last page